Published on: March 29, 2018 at 12:00PM
Condition: Non-small Cell Lung Cancer
Intervention: Combination Product: PET-based, dose-painted, accelerated chemoradiotherapy
Sponsor: Albert Einstein College of Medicine, Inc.
Recruiting
https://ift.tt/2GGHbiH
No comments:
Post a Comment